Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015 (2015), Article ID 867273, 8 pages
http://dx.doi.org/10.1155/2015/867273
Research Article

Evidence of Insulin Resistance and Other Metabolic Alterations in Boys with Duchenne or Becker Muscular Dystrophy

1Laboratorio de Biología Molecular, Unidad de Investigación Médica en Nutrición, Hospital de Pediatría, Centro Médico Nacional Siglo XXI, IMSS, Apartado Postal C-029 C. S.P.I. “Coahuila”, Coahuila No. 5, Colonia Roma, 06703 México, DF, Mexico
2Servicio de Electrodiagnóstico y Distrofia Muscular, Instituto Nacional de la Rehabilitación, México, DF, Mexico
3Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón s/n, Col. Casco de Santo Tomas, Delegación Miguel Hidalgo, 11340 México City, Mexico
4Subdirección de Enseñanza e Investigación, Centro Médico Nacional 20 de Noviembre, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, San Lorenzo 502 (2 Piso), Colonia Del Valle, Delegación Benito Juárez, 03100 México City, Mexico
5Unidad de Investigación Médica en Genética Humana, Hospital de Pediatría, Centro Médico Nacional Siglo XXI, IMSS, México, DF, Mexico

Received 12 August 2014; Revised 29 August 2014; Accepted 30 August 2014

Academic Editor: Nikolaos Papanas

Copyright © 2015 Maricela Rodríguez-Cruz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Bushby, R. Finkel, D. J. Birnkrant et al., “Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management,” The Lancet Neurology, vol. 9, no. 1, pp. 77–93, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. B. T. Darras, P. Blattner, J. F. Harper, A. J. Spiro, S. Alter, and U. Francke, “Intragenic deletions in 21 Duchenne muscular dystrophy (DMD)/Becker muscular dystrophy (BMD) families studied with the dystrophin cDNA: location of breakpoints on Hind III and BglII exon-containing fragment maps, meiotic and mitotic origin of the mutations,” American Journal of Human Genetics, vol. 43, pp. 620–629, 1988. View at Google Scholar
  3. E. F. Gillard, J. S. Chamberlain, E. G. Murphy et al., “Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene,” The American Journal of Human Genetics, vol. 45, no. 4, pp. 507–520, 1989. View at Google Scholar · View at Scopus
  4. R. Coral-Vazquez, D. Arenas, D. Cisneros et al., “Pattern of deletions of the dystrophin gene in Mexican Duchenne/Becker muscular dystrophy patients: the use of new designed primers for the analysis of the major deletion “hot spot” region,” The American Journal of Medical Genetics, vol. 70, pp. 240–246, 1997. View at Google Scholar
  5. A. P. Monaco, C. J. Bertelson, S. Liechti-Gallati, H. Moser, and L. M. Kunkel, “An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus,” Genomics, vol. 2, no. 1, pp. 90–95, 1988. View at Publisher · View at Google Scholar · View at Scopus
  6. J. M. Ervasti, K. Ohlendieck, S. D. Kahl, M. G. Gaver, and K. P. Campbell, “Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle,” Nature, vol. 345, no. 6273, pp. 315–319, 1990. View at Publisher · View at Google Scholar · View at Scopus
  7. K. A. Lapidos, R. Kakkar, and E. M. McNally, “The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma,” Circulation Research, vol. 94, no. 8, pp. 1023–1031, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. A. A. Hack, M. Y. J. Lam, L. Cordier et al., “Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex,” Journal of Cell Science, vol. 113, no. 14, pp. 2535–2544, 2000. View at Google Scholar · View at Scopus
  9. J. E. Brenman, D. S. Chao, H. Xia, K. Aldape, and D. S. Bredt, “Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy,” Cell, vol. 82, no. 5, pp. 743–752, 1995. View at Publisher · View at Google Scholar · View at Scopus
  10. J. B. Boord, A. L. Graber, J. W. Christman, and A. C. Powers, “Practical management of diabetes in critically ill patients,” The American Journal of Respiratory and Critical Care Medicine, vol. 64, pp. 1763–1767, 2001. View at Google Scholar
  11. C. Mulvey, E. Harno, A. Keenan, and K. Ohlendieck, “Expression of the skeletal muscle dystrophin-dystroglycan complex and syntrophin-nitric oxide synthase complex is severely affected in the type 2 diabetic Goto-Kakizaki rat,” European Journal of Cell Biology, vol. 84, no. 11, pp. 867–883, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. D. G. Allen and N. P. Whitehead, “Duchenne muscular dystrophy—what causes the increased membrane permeability in skeletal muscle?” The International Journal of Biochemistry and Cell Biology, vol. 43, no. 3, pp. 290–294, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. C. M. McDonald, G. T. Carter, R. T. Abresch et al., “Body composition and water compartment measurements in boys with Duchenne muscular dystrophy,” The American Journal of Physical Medicine and Rehabilitation, vol. 84, no. 7, pp. 483–491, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. M. C. Zanardi, A. Tagliabue, S. Orcesi, A. Berardinelli, C. Uggetti, and A. Pichiecchio, “Body composition and energy expenditure in Duchenne muscular dystrophy,” European Journal of Clinical Nutrition, vol. 57, no. 2, pp. 273–278, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. T.-N. Willig, L. Carlier, M. Legrand, H. Riviere, and J. Navarro, “Nutritional assessment in Duchenne muscular dystrophy,” Developmental Medicine and Child Neurology, vol. 35, no. 12, pp. 1074–1082, 1993. View at Google Scholar · View at Scopus
  16. S. Z. Yanovski and J. A. Yanovski, “Obesity,” The New England Journal of Medicine, vol. 346, no. 8, pp. 591–602, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. R. W. Taylor, I. E. Jones, S. M. Williams, and A. Goulding, “Body fat percentages measured by dual-energy x-ray absorptiometry corresponding to recently recommended body mass index cutoffs for overweight and obesity in children and adolescents aged 3–18 y,” The American Journal of Clinical Nutrition, vol. 76, no. 6, pp. 1416–1421, 2002. View at Google Scholar · View at Scopus
  18. J. Sambrook and D. Russell, “Preparation and analysis of eukaryotic genomic DNA,” in Molecular Cloning: A Laboratory Manual, C. Nolan, Ed., pp. 6.1–6.31, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA, 2001. View at Google Scholar
  19. J. S. Chamberlain, R. A. Gibbs, J. E. Ranier, P. N. Nguyen, and C. T. Caskey, “Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification,” Nucleic Acids Research, vol. 16, no. 23, pp. 11141–11156, 1988. View at Publisher · View at Google Scholar · View at Scopus
  20. A. H. Beggs, M. Koenig, F. M. Boyce, and L. M. Kunkel, “Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction,” Human Genetics, vol. 86, no. 1, pp. 45–48, 1990. View at Google Scholar · View at Scopus
  21. A. C. B. Rizzo, T. B. L. Goldberg, C. C. Silva, C. S. Kurokawa, H. R. C. Nunes, and J. E. Corrente, “Metabolic syndrome risk factors in overweight, obese, and extremely obese brazilian adolescents,” Nutrition Journal, vol. 12, no. 1, article no. 19, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Keskin, S. Kurtoglu, M. Kendirci, M. E. Atabek, and C. Yazici, “Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents,” Pediatrics, vol. 115, no. 4, pp. e500–e503, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. J. J. García, G. G. Rojas, and N. M. León, “Prevalencia de resistencia a la insulina y síndrome metabólico en niños obesos que acuden a la Clínica de Obesidad del Hospital Pediátrico de Sinaloa,” Pediatría de México, vol. 12, pp. 18–22, 2010. View at Google Scholar
  25. A. Leroy-Willig, T. N. Willig, M. C. Henry-Feugeas et al., “Body composition determined with MR in patients with Duchenne muscular dystrophy, spinal muscular atrophy, and normal subjects,” Magnetic Resonance Imaging, vol. 15, no. 7, pp. 737–744, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Ploug, B. van Deurs, H. Ai, S. W. Cushman, and E. Ralston, “Analysis of GLUT4 distribution in whole skeletal muscle fibers: identification of distinct storage compartments that are recruited by insulin and muscle contractions,” The Journal of Cell Biology, vol. 142, no. 6, pp. 1429–1446, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Groh, H. Zong, M. M. Goddeeris et al., “Sarcoglycan complex. Implications for metabolic defects in muscular dystrophies,” Journal of Biological Chemistry, vol. 284, no. 29, pp. 19178–19182, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. G. R. Freidenberg and J. M. Olefsky, “Dissociation of insulin resistance and decreased insulin receptor binding in Duchenne muscular dystrophy,” Journal of Clinical Endocrinology and Metabolism, vol. 60, no. 2, pp. 320–327, 1985. View at Publisher · View at Google Scholar · View at Scopus